Joseph E. Levi

LKQ Corporation (LKQ) told investors its approximately $2.1 billion acquisition of Uni-Select, including FinishMaster, would drive growth and strengthen...

A federal judge in New Jersey has dismissed the securities complaint filed against Cross River Bank, granting the bank’s...

A federal judge has allowed key portions of the securities lawsuit against Dick’s Sporting Goods (NYSE: DKS) to...

A federal judge dismissed the amended securities complaint against Arbor Realty Trust, Inc. (NYSE: ABR), finding that plaintiffs failed...

Upstart Holdings (UPST) told investors its newest AI model, Model 22, was improving approvals and supporting growth. But...

United Homes Group (UHG) aid its strategic review was all about maximizing shareholder value. But investors say the outcome was the opposite.  Investors...

Stellantis N.V. (STLA) said 2025 would bring profitable growth, while also publicly expressing confidence in THE growing electrification market and...

Babcock & Wilcox Enterprises (BW) told investors its AI data center power deal was a game-changer. The stock soared as...

New Era (NUAI) sold investors an AI-powered future. Big data center promises. Supposed to permit progress. A cutting-edge Texas project. But in December 2025,...

Medpace (MEDP) told investors cancellations were “well behaved” and that a 1.15 book-to-bill target remained achievable for the second half...

Gossamer (GOSS) told investors its Phase three PROSERA study was on track, with executives expressing confidence in the...

Aldeyra (ALDX) said its dry eye drug reproxalap had demonstrated broad-based, rapid-onset activity, consistent safety, and statistically significant, clinically relevant activity across Phase...

Vital Farms (VITL) said growth was strong and said it had adjusted the ERP launch timing to help...

Pinterest (PINS) told investors its advertising business was resilient and positioned to navigate macro uncertainty, including tariff-related pressure...

Babcock & Wilcox (BW) told investors it had landed a transformational AI data-center power deal worth over $1.5...

NEW YORK, April 17, 2026 — B&W promised investors a “$2.4 billion” contract that would transform the Company....

NEW YORK, April 17, 2026 — “Maximize shareholder value.” That was the promise United Homes Group, Inc. (NASDAQ:...

NEW YORK, April 17, 2026 — Baird Equity Research titled its February 9, 2026 report “Expect Shares Under...

NEW YORK, April 17, 2026 — When Stellantis N.V. (NYSE: STLA) reported its fiscal 2024 results on February...

NEW YORK, April 17, 2026 — Morgan Stanley slashed its price target on Upstart Holdings, Inc. (NASDAQ: UPST)...

NEW YORK, April 17, 2026 — “1 gigawatt” of AI-powered infrastructure capacity. “Tangible progress across all fronts.” Air...

NEW YORK, April 17, 2026 — On February 24, 2026, Wedbush downgraded Gossamer Bio, Inc. (NASDAQ: GOSS) to...

NEW YORK, April 17, 2026 — Institutional investors holding positions in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) during the...

Wall Street Reassessment: Analyst Opinion Evolution on PINS NEW YORK, April 17, 2026 — On November 4, 2025,...

Super Micro (SMCI) said it was dominating the AI surge. Record sales. Massive demand. A company on fire. But there...

ImmunityBio (IBRX) is facing a securities lawsuit alleging that the company and Patrick Soon-Shiong overstated what Anktiva could do in promotional statements,...

Atara (ATRA) told investors its cancer therapy was on track for FDA approval. Strong data. Priority review. A major...

United Homes (UHG) told investors it was exploring “strategic alternatives” to maximize shareholder value. It sounded disciplined. Thoughtful....

Lufax (LU) told investors its numbers were solid. Strong controls. Reliable profits. But a new lawsuit alleges the truth was very different. ...

Coty (COTY) told investors growth was back. Strong fragrance demand. Profits set to rebound. But the underlying trends told a...

Upstart (UPST) told investors its AI was getting smarter. Their AI model was supposed to approve more borrowers,...

Stellantis (STLA) told investors 2025 would be the year growth came back. Electrification was “growing,” margins were supposed to recover, and management...

Power Solutions (PSIX) said it was benefiting from strong data center demand. High growth. Higher margins. Big demand. But the...

Gartner (IT) projected steady growth and a path back toward double-digit gains. The complaint alleges that the picture was misleading.  Investors...

Hercules Capital (HTGC) told investors its lending machine was disciplined. Strong underwriting. Careful valuations. A portfolio built to...

Grocery Outlet (GO) looked like a growth story. New stores. Rising sales. A turnaround plan that seemed to be working. But...

Gemini (GEMI) pitched a global crypto platform. Growing users. Expanding worldwide. Growth ambitions. But that story didn’t last.  Gemini Space...

Concorde (CIGL) promoted technology-driven security services and recurring revenue. But according to a recently filed complaint, a coordinated...

New Era (NUAI) told investors it was pursuing an AI infrastructure strategy built around West Texas data-center development...

Medpace (MEDP) told investors cancellations were “well behaved” and a 1.15 book-to-bill was still in reach. Growth looked steady. Backlog looked strong. Confidence stayed high. But the complaint...

ChowChow Cloud (CHOW) touted its growth in cloud and AI-related services before a sharp stock collapse triggered securities fraud...

Alight (ALIT) promised a turnaround. New leadership. Strong growth. Reliable dividends. But that story didn’t hold.  A federal lawsuit filed against...

Trip.com (TCOM) told investors it was a leading global one-stop travel service provider and the go-to destination for...

Oddity Tech (ODD) told investors its AI-powered beauty platform was thriving. Growth was strong. Guidance kept rising. But behind the...

Camping World (CWH) told investors its inventory strategy and analytics were driving stronger performance. Smart inventory. Strong performance. A...

Pinterest (PINS) told investors it had built a resilient ad machine. Tariffs, macro pressure, retail weakness. None of...

Gossamer (GOSS) told investors its Phase 3 PROSERA study was progressing, with executives expressing confidence in the trial’s...

Snowflake (SNOW) looked unstoppable. Surging consumption. Confident forecasts. A bold ten billion dollar revenue target. But behind the scenes, efficiency changes,...

Coty ($COTY) told investors a comeback was already underway. Growth was coming back. Profits were set to rebound....

Aldeyra Therapeutics ($ALDX) told investors its dry eye drug reproxalap was showing strong, consistent results across multiple late-stage...